Literature DB >> 10718829

Insulin-like growth factor (IGF)-1 and IGF-binding protein-1 concentrations in serum of normal subjects after alcohol ingestion: evidence for decreased IGF-1 bioavailability.

S Röjdmark1, Y Rydvald, A Aquilonius, K Brismar.   

Abstract

OBJECTIVE: Both insulin-like growth factor (IGF)-1 and insulin-like growth factor-binding protein (IGFBP)-1 are synthesized by the liver. It is well known that chronic alcohol abuse impairs liver function, but less is known about how an acute intake of moderate quantities of alcohol affects hepatic production of IGF-1 and IGFBP-1. The objective of the present investigation was to study this issue by measuring serum levels of IGF-1 and IGFBP-1 in normal subjects before, during and after ingestion of a moderate dose of ethanol. SUBJECTS AND
DESIGN: Eight healthy subjects were tested on two occasions. On one occasion (experiment A), three 150-ml doses of ordinary drinking-water were given at 08.00, 09.30, and 11.00 h. On another occasion (experiment B), three 150-ml drinks of diluted ethanol were given instead of water. Each drink contained 0.45 g ethanol/kg b.w. Experiments A and B were performed in random order, 1 week apart. Blood samples were collected before, during and after the drinks over a period of 7 h (08.00-15.00 h). One blood sample was also drawn at 08.00 h the following day. MEASUREMENTS: Blood glucose and serum concentrations of ethanol, insulin, growth hormone (GH), IGF-1 and IGFBP-1 were determined.
RESULTS: When alcohol had been ingested, the serum ethanol concentration rose to a peak value of 28.6 +/- 0.9 mmol/l (mean +/- SEM). The serum IGF-1 level declined significantly toward the end of the 7-h period. The serum IGFBP-1 level increased promptly in response to ethanol, and reached a maximum 2.7 times above basal as the ethanol level peaked. Neither IGF-1, nor IGFBP-1 levels changed significantly after water intake. The IGF-1 : IGFBP-1 ratio declined markedly after ethanol (from 15.7 +/- 3.9 to 3.9 +/- 0.6; P < 0.01), but not after water intake. The blood glucose and serum levels of insulin and GH were unaffected by both ethanol and water.
CONCLUSIONS: Ingestion of moderate amounts of alcohol by healthy individuals results in an acute and profound increase in the serum IGFBP-1 level and a protracted and less powerful decline in the IGF-1 level. The mechanism behind the IGFBP-1 increase is probably a direct effect on the liver, since neither insulin, nor glucose or GH concentrations changed significantly in response to the ethanol challenge.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718829     DOI: 10.1046/j.1365-2265.2000.00908.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  IGF-1: a potential biomarker for efficacy of sleep improvement with automatic airway pressure therapy for obstructive sleep apnea?

Authors:  Vincent Mysliwiec; Jessica Gill; Panagiotis Matsangas; Tristin Baxter; Taura Barr; Bernard J Roth
Journal:  Sleep Breath       Date:  2015-02-28       Impact factor: 2.816

2.  Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence.

Authors:  S Röjdmark; K Brismar
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

3.  Effects of betaine on ethanol-stimulated secretion of IGF-I and IGFBP-1 in rat primary hepatocytes: involvement of p42/44 MAPK activation.

Authors:  Myeong Soo Lee; Myung-Sunny Kim; Soo Young Park; Chang-Won Kang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

4.  Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment.

Authors:  Sven Röjdmark; Jan Calissendorff; Olle Danielsson; Kerstin Brismar
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

Review 5.  Alcohol: A Simple Nutrient with Complex Actions on Bone in the Adult Skeleton.

Authors:  Gino W Gaddini; Russell T Turner; Kathleen A Grant; Urszula T Iwaniec
Journal:  Alcohol Clin Exp Res       Date:  2016-03-12       Impact factor: 3.455

6.  Effects of graded increases in ethanol consumption on biochemical markers of bone turnover in young adult male cynomolgus macaques.

Authors:  Lara H Sattgast; Adam J Branscum; Nicole A R Walter; Natali Newman; Steven W Gonzales; Kathleen A Grant; Russell T Turner; Urszula T Iwaniec
Journal:  Alcohol       Date:  2021-02-03       Impact factor: 2.405

7.  Deficiency of insulin-like growth factor 1 reduces vulnerability to chronic alcohol intake-induced cardiomyocyte mechanical dysfunction: role of AMPK.

Authors:  Wei Ge; Qun Li; Subat Turdi; Xiao-Ming Wang; Jun Ren
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

8.  The apéritif effect: Alcohol's effects on the brain's response to food aromas in women.

Authors:  William J A Eiler; Mario Džemidžić; K Rose Case; Christina M Soeurt; Cheryl L H Armstrong; Richard D Mattes; Sean J O'Connor; Jaroslaw Harezlak; Anthony J Acton; Robert V Considine; David A Kareken
Journal:  Obesity (Silver Spring)       Date:  2015-07       Impact factor: 5.002

9.  Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease.

Authors:  Heng-Hong Li; Kathryn Doiron; Andrew D Patterson; Frank J Gonzalez; Albert J Fornace
Journal:  J Transl Med       Date:  2013-10-23       Impact factor: 5.531

10.  The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.

Authors:  Eleanor L Watts; Aurora Perez-Cornago; Paul N Appleby; Demetrius Albanes; Eva Ardanaz; Amanda Black; H Bas Bueno-de-Mesquita; June M Chan; Chu Chen; S A Paul Chubb; Michael B Cook; Mélanie Deschasaux; Jenny L Donovan; Dallas R English; Leon Flicker; Neal D Freedman; Pilar Galan; Graham G Giles; Edward L Giovannucci; Marc J Gunter; Laurel A Habel; Christel Häggström; Christopher Haiman; Freddie C Hamdy; Serge Hercberg; Jeff M Holly; Jiaqi Huang; Wen-Yi Huang; Mattias Johansson; Rudolf Kaaks; Tatsuhiko Kubo; J Athene Lane; Tracy M Layne; Loic Le Marchand; Richard M Martin; E Jeffrey Metter; Kazuya Mikami; Roger L Milne; Howard A Morris; Lorelei A Mucci; David E Neal; Marian L Neuhouser; Steven E Oliver; Kim Overvad; Kotaro Ozasa; Valeria Pala; Claire H Pernar; Michael Pollak; Mari-Anne Rowlands; Catherine A Schaefer; Jeannette M Schenk; Pär Stattin; Akiko Tamakoshi; Elin Thysell; Mathilde Touvier; Antonia Trichopoulou; Konstantinos K Tsilidis; Stephen K Van Den Eeden; Stephanie J Weinstein; Lynne Wilkens; Bu B Yeap; Timothy J Key; Naomi E Allen; Ruth C Travis
Journal:  Int J Cancer       Date:  2019-04-04       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.